IN this issue of Anesthesiology, Sankar et al.1 report the results of a Monte Carlo simulation comparing the cost-effectiveness of using sleep apnea screening for preventing perioperative complications and improving long-term outcomes in patients with obstructive sleep apnea (OSA). Cost-effectiveness analysis quantifies the incremental cost and benefit of selecting a more expensive and more effective healthcare intervention (OSA screening plus polysomnography) compared to a less costly and less effective intervention (no screening). The incremental cost-effectiveness ratio is the ratio of the difference in cost of two interventions divided by the difference in outcome (where outcome is measured in terms of quality-adjusted life-years). The cost-effectiveness ratio can be thought of as the additional cost of achieving 1 yr of perfect life (the quality-adjusted life-year)2 using the more effective intervention. Historically, interventions have been considered cost-effective...
Preoperative Screening for Obstructive Sleep Apnea to Improve Long-term Outcomes
This editorial accompanies the article on p. 787.
Accepted for publication July 7, 2020. Published online first on August 11, 2020.
- Views Icon Views
- Share Icon Share
- Search Site
Jacob W. Nadler, Suzanne B. Karan, Laurent G. Glance; Preoperative Screening for Obstructive Sleep Apnea to Improve Long-term Outcomes. Anesthesiology 2020; 133:702–704 doi: https://doi.org/10.1097/ALN.0000000000003492
Download citation file: